Skip to main content

Advertisement

Log in

Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease

  • Neuroimaging (DJ Brooks, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Sleep disorders are commonly observed in patients with neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease and often represent an early manifestation of the underlying degenerative process. The pathophysiology of sleep dysfunction in these conditions is complex and incompletely understood. However, in recent years, functional imaging in vivo with SPECT and PET has significantly improved our understanding of the possible molecular mechanisms. These include dysfunction of both dopaminergic and non-dopaminergic pathways involved in sleep/wakefulness control. This paper summarizes the main findings of the imaging studies performed to elucidate the aetiology of sleep disorders in Alzheimer’s disease and Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Raggi A, Ferri R. Sleep disorders in neurodegenerative diseases. Eur J Neurol. 2010;17(11):1326–38.

    CAS  PubMed  Google Scholar 

  2. Schrempf W, Brandt MD, Storch A, Reichmann H. Sleep disorders in Parkinson’s disease. J Parkinsons Dis. 2014;4(2):211–21.

    PubMed  Google Scholar 

  3. McCurry SM, Ancoli-Israel S. Sleep dysfunction in Alzheimer’s disease and other dementias. Curr Treat Options Neurol. 2003;5(3):261–72.

    Article  PubMed  Google Scholar 

  4. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12(5):443–53.

    Article  PubMed  Google Scholar 

  5. Karlsson KA, Kreider JC, Blumberg MS. Hypothalamic contribution to sleep-wake cycle development. Neuroscience. 2004;123(2):575–82.

    Article  CAS  PubMed  Google Scholar 

  6. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci. 2002;5(Suppl):1071–5.

    Article  CAS  PubMed  Google Scholar 

  7. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci. 2003;23(1):7–11.

    CAS  PubMed  Google Scholar 

  8. Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol. 2008;6(4):367–78.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15) O PET study. Brain. 1997;120(Pt 7):1173–97.

    Article  PubMed  Google Scholar 

  10. Maquet P, Degueldre C, Delfiore G, Aerts J, Péters JM, Luxen A, et al. Functional neuroanatomy of human slow wave sleep. J Neurosci. 1997;17(8):2807–12.

    CAS  PubMed  Google Scholar 

  11. Maquet P. Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Res. 2000;9(3):207–31.

    Article  CAS  PubMed  Google Scholar 

  12. Buchsbaum MS, Hazlett EA, Wu J, Bunney WE. Positron emission tomography with deoxyglucose-F18 imaging of sleep. Neuropsychopharmacology. 2001;25 Suppl 5:S50–6.

    Article  CAS  PubMed  Google Scholar 

  13. Oswald, I. In: Sleep. London: Pelican (ed). (1966).

  14. Maquet P, Peters J, Aerts J, et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature. 1996;383:163–6.

    Article  CAS  PubMed  Google Scholar 

  15. Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY. Forebrain activation in REM sleep: an FDG PET study. Brain Res. 1997;770(1–2):192–201.

    Article  CAS  PubMed  Google Scholar 

  16. Siegel JM. REM sleep: a biological and psychological paradox. Sleep Med Rev. 2011;15(3):139–42.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Ho AP, Gillin JC, Buchsbaum MS, et al. Brain glucose metabolism during non-rapid eye movement sleep in major depression: a positron emission tomography study. Arch Gen Psychiatry. 1996;53:645–52.

    Article  CAS  PubMed  Google Scholar 

  18. Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, et al. Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F] FDG PET studies. Psychiatry Res. 1999;91(2):59–78.

    Article  CAS  PubMed  Google Scholar 

  19. Nofzinger EA, Berman S, Fasiczka A, et al. Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using [18F]-FDG PET. Psychiatry Res. 2001;106:95–111.

    Article  CAS  PubMed  Google Scholar 

  20. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004;161(11):2126–8.

    Article  PubMed  Google Scholar 

  21. Nofzinger EA. What can neuroimaging findings tell us about sleep disorders? Sleep Med. 2004;5 Suppl 1:S16–22.

    Article  PubMed  Google Scholar 

  22. Li Y, Wang E, Zhang H, Dou S, Liu L, Tong L, et al. Functional connectivity changes between parietal and prefrontal cortices in primary insomnia patients: evidence from resting-state fMRI. Eur J Med Res. 2014;19(1):32.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Vitiello MV, Prinz PN, Williams DE, Frommlet MS, Ries RK. Sleep disturbances in patients with mild-stage Alzheimer’s disease. J Gerontol. 1990;45(4):M131–8.

    Article  CAS  PubMed  Google Scholar 

  24. McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol. 1999;12(2):53–9.

    Article  CAS  PubMed  Google Scholar 

  25. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Med. 2005;6(4):347–52.

    Article  PubMed  Google Scholar 

  26. Song Y, Dowling GA, Wallhagen MI, Lee KA, Strawbridge WJ. Sleep in older adults with Alzheimer’s disease. J Neurosci Nurs. 2010;42(4):190–8.

    Article  PubMed  Google Scholar 

  27. Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, et al. Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment. J Sleep Res. 2005;14(3):311–7.

    Article  PubMed  Google Scholar 

  28. Gagnon JF, Petit D, Fantini ML, Rompré S, Gauthier S, Panisset M, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep. 2006;29(10):1321–5.

    PubMed  Google Scholar 

  29. Kundermann B, Thum A, Rocamora R, Haag A, Krieg JC, Hemmeter U. Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer’s disease and frontotemporal dementia. J Psychiatr Res. 2011;45(12):1585–92.

    Article  PubMed  Google Scholar 

  30. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15:777–96.

    Article  CAS  PubMed  Google Scholar 

  31. Okawa M, Mishima K, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep. 1991;14(6):478–85.

    CAS  PubMed  Google Scholar 

  32. Yevchak AM, Steis MR, Evans LK. Sundown syndrome: a systematic review of the literature. Res Gerontol Nurs. 2012;5(4):294–303.

    Article  PubMed  Google Scholar 

  33. Ismail Z, Herrmann N, Francis PL, Rothenburg LS, Lobaugh NJ, Leibovitch FS, et al. A SPECT study of sleep disturbance and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2009;27(3):254–9.

    Article  CAS  PubMed  Google Scholar 

  34. Eggers C, Szelies B, Bauer B, Wienhard K, Schröder H, Herholz K, et al. Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness. Eur J Neurol. 2007;14(6):690–3.

    Article  CAS  PubMed  Google Scholar 

  35. Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537–43. This is an interesting study as it suggests that sleep disturbance might cause or accelerate Alzheimer’s disease. The findings need to be confirmed in future studies.

    PubMed  Google Scholar 

  36. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbance in persons with Alzheimer’s disease and normal elderly. J Sleep Res. 2005;14(2):177–85.

    Article  PubMed  Google Scholar 

  38. Cheng CY, Tsai CF, Wang SJ, Hsu CY, Fuh JL. Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia. J Geriatr Psychiatry Neurol. 2013;26(3):158–64.

    Article  PubMed  Google Scholar 

  39. Chaudhuri KR. Nocturnal symptom complex in PD and its management. Neurology. 2003;61 Suppl 3:S17–23.

    Article  CAS  PubMed  Google Scholar 

  40. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA. 2002;287(4):455–63.

    Article  PubMed  Google Scholar 

  41. Rye DB. Excessive daytime sleepiness and unintended sleep in Parkinson’s disease. Curr Neurol Neurosci Rep. 2006;6(2):169–76.

    Article  PubMed  Google Scholar 

  42. Comella CL. Sleep disorders in Parkinson’s disease. Curr Treat Options Neurol. 2008;10(3):215–21.

    Article  PubMed  Google Scholar 

  43. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology. 2002;58(3):341–6.

    Article  PubMed  Google Scholar 

  44. Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson’s disease. J Neurol. 2007;254(8):1037–43.

    Article  PubMed  Google Scholar 

  45. Happe S, Pirker W, Klösch G, Sauter C, Zeitlhofer J. Periodic leg movements in patients with Parkinson’s disease are associated with reduced striatal dopamine transporter binding. J Neurol. 2003;250(1):83–6.

    Article  PubMed  Google Scholar 

  46. Happe S, Anderer P, Pirker W, Klösch G, Gruber G, Saletu B, et al. Sleep microstructure and neurodegeneration as measured by [123I] beta-CIT SPECT in treated patients with Parkinson’s disease. J Neurol. 2004;251(12):1465–71.

    Article  PubMed  Google Scholar 

  47. Pavese N, Metta V, Simpson BS, Murphy TA, Ramlackhansingh A, Chaudhuri KR, et al. Sleep regulatory centres dysfunction in Parkinson’s disease patients with excessive daytime sleepiness. An in vivo PET study. Parkinsonism Relat Disord. 2012;18(Supplement 2):S24–5. In this paper, eleven Parkinson’s disease patients (PD) with Excessive daytime sleepiness (EDS) and ten without EDS were assessed with 18F-dopa and 11C-DASB. For each tracer, PET findings in PD patients were compared with those of ten healthy volunteers. PET images were analyzed with region of interest approach and whole brain voxel-by-voxel analysis. Both methods provide evidence that monoaminergic dysfunction in the neuronal networks responsible for the establishment and maintenance of wakefulness contributes to EDS in PD.

    Article  Google Scholar 

  48. Gama RL, Távora DG, Bomfim RC, Silva CE, de Bruin VM, de Bruin PF. Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy—a comparative study. Parkinsonism Relat Disord. 2010;16(4):275–9.

    Article  PubMed  Google Scholar 

  49. Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, et al. Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness. Parkinsonism Relat Disord. 2006;12(5):319–22.

    Article  PubMed  Google Scholar 

  50. Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, et al. Excessive daytime sleepiness in Parkinson disease: a SPECT study. Sleep. 2006;29(7):917–20.

    PubMed  Google Scholar 

  51. Hilker R, Razai N, Ghaemi M, Weisenbach S, Rudolf J, Szelies B, et al. [18F] fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson’s disease. Clin Neurol Neurosurg. 2003;105(4):262–9.

    Article  PubMed  Google Scholar 

  52. Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, et al. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C] DASB PET imaging study. PLoS One. 2012;7(7):e40166.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry. 1997;58:369–76.

    Article  CAS  PubMed  Google Scholar 

  54. Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep. 2000;23(4):513–7.

    CAS  PubMed  Google Scholar 

  55. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51(2):526–9.

    Article  CAS  PubMed  Google Scholar 

  56. Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. J Neurol Neurosurg Psychiatry. 2008;79(4):387–91.

    Article  CAS  PubMed  Google Scholar 

  57. Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T, et al. Relationship between (123) I-MIBG scintigrams and REM sleep behavior disorder in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(10):683–5.

    Article  PubMed  Google Scholar 

  58. Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol. 2012;71(4):560–8. Findings from this study provide evidence that cholinergic dysfunction rather than degeneration of monoaminergic pathways are involved in the occurrence of RBD in Parkinson’s disease

  59. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572–7.

    Article  PubMed  Google Scholar 

  60. Postuma RB, Gagnon JF, Rompré S, Montplaisir JY. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010;74(3):239–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011;10(9):797–805.

    Article  CAS  PubMed  Google Scholar 

  62. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep. 2003;26(5):507–12.

    PubMed  Google Scholar 

  63. Kim YK, Yoon IY, Kim JM, Jeong SH, Kim KW, Shin YK, et al. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol. 2010;17(3):487–92.

    Article  CAS  PubMed  Google Scholar 

  64. Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82(7):620–7. Findings from this study are very interesting as they indicate that patients with REM sleep behavior disorder have latent network abnormalities that could be predictive of subsequent phenoconversion to Parkinson’s disease or other synucleinopathies.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Nicola Pavese declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicola Pavese.

Additional information

This article is part of the Topical Collection on Neuroimaging

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pavese, N. Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease. Curr Neurol Neurosci Rep 14, 501 (2014). https://doi.org/10.1007/s11910-014-0501-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-014-0501-5

Keywords

Navigation